HopeStage
Back to all studies
RecruitingNCT05802446

Real-time fMRI neurofeedback for mood symptoms between episodes in people with bipolarity

About this title

Neurofeedback for Bipolar Disorder

Read the official source — NCT05802446
Interventional studyAges 18–65France
The study in practice

Understand this study

Who could participate?

This study is for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Listed locations
CréteilSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 22, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
64
Sponsor
Assistance Publique - Hôpitaux de Paris
Sponsor type
Unknown or unclear
Study type
Other
Intervention type
OTHER
Study phase
Not clearly listed
Locations
France
Age range
From 18 Years to 65 Years
Official registry ID
NCT05802446
Official title
Show the full official title

Real-time fMRI Neurofeedback as Treatment for Inter-critical Mood Symptoms in Bipolar Disorder : a Randomized Controlled Multicentric Trial

Recruitment & locations

Recruiting

Créteil

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Assistance Publique - Hôpitaux de Paris.

Who can participate?

This study is for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies